Abstract | BACKGROUND: METHODS: We measured the effects of NAc DBS in 15 patients on the dopamine D2/3 receptor availability in the striatum with [(123)I]iodobenzamide ([(123)I] IBZM) single photon emission computed tomography. We correlated changes in [(123)I] IBZM binding potential (BP) with plasma levels of homovanillic acid (HVA) and clinical symptoms. RESULTS: Acute (1-hour) and chronic (1-year) DBS decreased striatal [(123)I] IBZM BP compared with the nonstimulated condition in the putamen. BP decreases were observed after 1 hour of stimulation, and chronic stimulation was related to concurrent HVA plasma elevations, implying DBS-induced dopamine release. BP decreases in the area directly surrounding the electrodes were significantly correlated with changes in clinical symptoms (45% symptom decrease). CONCLUSIONS: NAc DBS induced striatal dopamine release, which was associated with increased HVA plasma levels and improved clinical symptoms, suggesting that DBS may compensate for a defective dopaminergic system.
|
Authors | Martijn Figee, Pelle de Koning, Sanne Klaassen, Nienke Vulink, Mariska Mantione, Pepijn van den Munckhof, Richard Schuurman, Guido van Wingen, Thérèse van Amelsvoort, Jan Booij, Damiaan Denys |
Journal | Biological psychiatry
(Biol Psychiatry)
Vol. 75
Issue 8
Pg. 647-52
(Apr 15 2014)
ISSN: 1873-2402 [Electronic] United States |
PMID | 23938318
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2014 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Iodobenzenes
- Receptors, Dopamine D2
- Receptors, Dopamine D3
- idobenzamide
- Dopamine
- Homovanillic Acid
|
Topics |
- Adult
- Corpus Striatum
(diagnostic imaging, physiopathology)
- Deep Brain Stimulation
(methods)
- Dopamine
(metabolism)
- Female
- Homovanillic Acid
(blood)
- Humans
- Iodobenzenes
- Magnetic Resonance Imaging
- Male
- Obsessive-Compulsive Disorder
(diagnostic imaging, physiopathology, therapy)
- Putamen
(diagnostic imaging, metabolism)
- Receptors, Dopamine D2
(metabolism)
- Receptors, Dopamine D3
(metabolism)
- Severity of Illness Index
- Time Factors
- Tomography, Emission-Computed, Single-Photon
- Treatment Outcome
|